Skip to content

Clinical trials

Completed Phase 2 Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Phase 2 Status: Completed Clear all

543 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200036
200121
200223
200328
200439
200538
200633
200729
200831
200920
201020
201122
201213
201312
201411
20159
20168
201711
201813
20192
20201
20215
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed543

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center45
Memorial Sloan Kettering Cancer Center38
Alliance for Clinical Trials in Oncology31
National Cancer Institute (NCI)21
SWOG Cancer Research Network15
Fred Hutchinson Cancer Center13
Case Comprehensive Cancer Center12
Jonsson Comprehensive Cancer Center11
Northwestern University9
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins9

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma543
Lymphoma, Non-Hodgkin172
Lymphoma, Large B-Cell, Diffuse158
Lymphoma, Follicular149
Leukemia144
Leukemia, Lymphocytic, Chronic, B-Cell124
Lymphoma, Mantle-Cell122
Hodgkin Disease119
Burkitt Lymphoma104
Lymphoma, Large-Cell, Immunoblastic95

Trials

Showing 1 to 25 of 543. Each trial links to its page on Pharma Observatory.

443 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.